Today’s pharmaceuticals businesses deal with many competing pressures, not least the drive to improve ethical business standards

This involves going beyond laws and regulations, establishing new approaches to stakeholder interactions and creating new relationships built on trust and shared values – not easy changes to make in a large corporation.

However, there are a number of current opportunities in the sector – partnering with governments, reaching into developing global markets and discovering sustainable solutions to keep up with the demand for ethical drugs.